Although cardiac resynchronization therapy (CRT) is an evidence-based effective therapy
of symptomatic heart failure with reduced ejection fraction (HFrEF), refractory to
optimal medical treatment and associated with intraventricular conduction disturbance,
the non-response rate to CRT is still around 30% [...]
